图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
国际药用蘑菇期刊
影响因子: 1.423 5年影响因子: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN 打印: 1521-9437
ISSN 在线: 1940-4344

国际药用蘑菇期刊

DOI: 10.1615/IntJMedMushrooms.2017024372
pages 839-848

Identification and Evaluation of Bioactivity of Compounds from the Mushroom Pleurotus nebrodensis (Agaricomycetes) against Breast Cancer

Jingfeng Hao
School of Chemical Engineering and Technology, Tianjin University, Tianjin, China
Xueya Zhang
School of Chemical Engineering and Technology, Tianjin University, Tianjin, China
Wancong Yu
Tianjin Research Center of Agricultural Biotechnology, Tianjin, China
Ru Wang
School of Chemical Engineering and Technology, Tianjin University, Tianjin, China
Zhaohui Xue
School of Chemical Engineering and Technology, Tianjin University, Tianjin, China
Xiaohong Kou
School of Chemical Engineering and Technology, Tianjin University, Tianjin, China

ABSTRACT

Breast cancer affects millions of women annually worldwide and is the leading cause of cancer death in women. Various bioactive phytochemicals based on natural products are considered to be an important source of chemopreventive agents. In this study we report−to our knowledge for the first time−9 phytochemicals isolated by nuclear magnetic resonance spectroscopy and mass spectrometry from the acetic ether extract of Pleurotus nebrodensis and identified as (1) ergosterol, (2) uracil, (3) ergosterol-3-O-β-D-glucopyranoside, (4) cerevisterol, (5) cerebroside B, (6) 5'-methylthioadenosine, (7) adenosine, (8) hypoxanthine, and (9) uridine. Their bioactivities were screened with an MTT assay using breast cancer MCF-7 cells in vitro. As a result, about half of the isolated compounds demonstrated moderate or strong inhibitory activity in a concentration-dependent manner. Among them, compound 1 (ergosterol) exhibited superior activity and the lowest half-maximal inhibitory concentration (112.65 μmol/L). Further mechanistic study elucidated that compound 1 led to significant S-phase cell cycle arrest and induced apoptosis in MCF-7 cells. Our study shows the mycochemical composition of the P. nebrodensis mushroom and provides guidance for use of compound 1 as a promising lead in cancer therapy.


Articles with similar content:

Medicinal Mushroom Extracts Possess Differential Antioxidant Activity and Cytotoxicity to Cancer Cells
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 5
Eglal AbdAllah Ghonimy, Mahomud Mohammed Alassar, Fang-Sheng Wu, Eman Nasr Elbatrawy
Antiproliferative Activity of Some Higher Mushrooms from Hungary against Human Cancer Cell Lines
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 12
Attila Vanyolos, Istvan Zupko, Noemi Bozsity, Judit Hohmann, Bernadett Kovacs
Growth-Inhibitory and Immunomodulatory Activities of Wild Mushrooms from North-Central British Columbia (Canada)
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 6
Chow H. Lee, Vicky Myhre, Aaron Smith, Sumreen Javed, Linda E. Tackaberry, Ankush Barad, Keith N. Egger, Kerry Reimer, Hugues B. Massicotte, Wai Ming Li, Geoffrey W. Payne
Enhanced Antiproliferative Effects of Aqueous Extracts of Some Medicinal Mushrooms on Colon Cancer Cells
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 3
Shagun Arora, Jay Balani, Simran Tandon, Shristhi Goyal
Comparison of Antioxidant and Antiproliferation Activities of Polysaccharides from Eight Species of Medicinal Mushrooms
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 3
Yangyang Yong, Yifan Gu, Zeliang Wang, Shizhu Zhang, Peiying Chen, Ling Lu